VioQuest Pharmaceuticals, Inc.
VOQP · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $3,805 | $1,485 |
| % Growth | – | -100% | 156.2% | – |
| Cost of Goods Sold | $0 | $0 | $2,427 | $838 |
| Gross Profit | $0 | $0 | $1,377 | $647 |
| % Margin | – | – | 36.2% | 43.6% |
| R&D Expenses | $4,988 | $1,820 | $9,394 | $902 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3,791 | $3,455 | $4,830 | $3,628 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $8,779 | $5,281 | $14,491 | $4,709 |
| Operating Income | $9,742 | $5,281 | $13,114 | $4,062 |
| % Margin | – | – | 344.7% | 273.5% |
| Other Income/Exp. Net | -$2,089 | $0 | -$8,123 | -$337 |
| Pre-Tax Income | -$10,869 | $0 | -$13,071 | $0 |
| Tax Expense | -$241 | $2,990 | -$236 | -$38 |
| Net Income | -$10,892 | -$8,271 | -$12,835 | -$4,024 |
| % Margin | – | – | -337.3% | -270.9% |
| EPS | -2.33 | -2.08 | -5.82 | -2.35 |
| % Growth | -12% | 64.3% | -147.7% | – |
| EPS Diluted | -2.33 | -2.08 | -5.82 | -2.35 |
| Weighted Avg Shares Out | 4,672 | 3,979 | 2,203 | 1,710 |
| Weighted Avg Shares Out Dil | 4,672 | 3,979 | 2,203 | 1,710 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $106 | $43 | $38 |
| Interest Expense | $1,126 | $0 | $0 | $0 |
| Depreciation & Amortization | $1,204 | $6 | $267 | $475 |
| EBITDA | -$6,612 | -$5,153 | -$10,352 | -$3,586 |
| % Margin | – | – | -272.1% | -241.5% |